Medical Health & Life Science Research News

Discover the next generation antibody therapeutics market review

Medical Market Research

Next generation antibody therapeutics have high efficiency and are more safe. Rapid advancements in monoclonal antibodies technology is the reason for this.

The Global Next Generation Antibody Therapeutics market size was around USD 3 billion in 2017. It is expected to grow at a CAGR of 13% to reach USD 5.53 billion by 2022.

These advances have improved bifunctional properties, decreased functional size along with immunogenicity. Several medical conditions like cancer; autoimmune diseases.

are treated using these technologies because of its enhanced properties.

Rising number of cases of chronic diseases, rapid advancements in technology, higher investment in R&D and increasing healthcare expenditure are the primary drivers of market growth.

On the other hand, strict administrative guidelines and regulatory requirements and inordinate delays in approval for new drugs along with their high costs are the primary restraints of market growth.

The market is segmented by therapeutic application and by technology. Classification by therapeutic application entails Oncology and Autoimmune/Inflammatory Diseases.

Classification by technology entails Antibody-Drug Conjugates (ADCs), Bispecific Antibodies (BsAbs), Fc Engineered Antibodies, Antibody Fragments and Antibody-like Proteins, and Biosimilar Antibody Products. Biosimilar antibody products in the technology segment accounted for the largest market share thereby dominating the market in the forecast period.

Oncology sub-category in the therapeutics application market category captured largest market share and is expected to remain in the lead till 2022.

Classification by geography entails North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. North America dominates the market with the largest market share.

US is the leader in the North American market. Europe is the second largest market and is expected to remain so though bridging the deficit with North America towards the tail end of the forecast period.

Asia Pacific is likely to be the fastest growing market with the highest CAGR in the forecast period. Economic boom in the emerging economies of India and China are the reasons for this.

Latin America is anticipated to experience sluggish growth while MEA continues to be the least attractive market in the forecast period.

Report: orbisresearch.com/contacts/request-sample/2068534

Key players in the market include Roche, Seattle Genetics, Takeda, Dyax Corp., and Immunogen. Other players in the market include Amgen, Inc., Biogen, Kyowa Hakko Kirin Co., Ltd., AstraZeneca, Pfizer, Inc., and Xencor, Inc.

Major points from Table of Contents:
1. Introduction
2. Research Methodology
3. Overview
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
5. Market Segmentation
6. Geographical Analysis
7. Strategic Analysis
8. Market Leaders' Analysis
9. Competitive Landscape
10. Market Outlook and Investment Opportunities

Report: orbisresearch.com/contacts/2068534

Few Points from List of Figures:
Global Next Generation Antibody Therapeutics Market By Region, From 2016-2022 ( USD Billion )
Global Next Generation Antibody Therapeutics Market By Technology, From 2016-2022 ( USD Billion )
Global Antibody-Drug Conjugates (ADCs) Market By Region, From 2016-2022 ( USD Billion )
Global Bispecific Antibodies (BsAbs) Market By Region, From 2016-2022 ( USD Billion )
Global Fc Engineered Antibodies Market By Region, From 2016-2022 ( USD Billion )
Global Antibody Fragments and Antibody-like Proteins Market By Region, From 2016-2022 ( USD Billion )
Global Biosimilar Antibody Products Market By Region, From 2016-2022 ( USD Billion )
Global Next Generation Antibody Therapeutics Market By Therapeutic Application, From 2016-2022 ( USD Billion )
Global Oncology Market By Region, From 2016-2022 ( USD Billion )
Global Autoimmune/Inflammatory Diseases Market By Region, From 2016-2022 ( USD Billion )
North America Next Generation Antibody Therapeutics Market By Technology, From 2016-2022 ( USD Billion )
North America Antibody-Drug Conjugates (ADCs) Market By Region, From 2016-2022 ( USD Billion )
North America Bispecific Antibodies (BsAbs) Market By Region, From 2016-2022 ( USD Billion )
North America Fc Engineered Antibodies Market By Region, From 2016-2022 ( USD Billion )
North America Antibody Fragments and Antibody-like Proteins Market By Region, From 2016-2022 ( USD Billion )
North America Biosimilar Antibody Products Market By Region, From 2016-2022 ( USD Billion )
North America Next Generation Antibody Therapeutics Market By Therapeutic Application, From 2016-2022 ( USD Billion )

 

News From

Orbis Research - Rendering Conscientious ResearchOrbis Research
Category: Market Research Publishers and RetailersCompany about: Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have a vast database of reports from the leading publishers and authors across the gl obe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their need, and we produce the perfect requi ...
This email address is being protected from spambots. You need JavaScript enabled to view it.